Authors:
DOYLE IR
HERMANS C
BERNARD A
NICHOLAS TE
BERSTEN AD
Citation: Ir. Doyle et al., CLEARANCE OF CLARA CELL SECRETORY PROTEIN 16 (CC16) AND SURFACTANT PROTEIN-A AND PROTEIN-B FROM BLOOD IN ACUTE RESPIRATORY-FAILURE, American journal of respiratory and critical care medicine, 158(5), 1998, pp. 1528-1535
Authors:
DOYLE IR
DAVIDSON KG
BARR HA
NICHOLAS TE
PAYNE K
Citation: Ir. Doyle et al., QUANTITY AND STRUCTURE OF SURFACTANT PROTEINS VARY AMONG PATIENTS WITH ALVEOLAR PROTEINOSIS, American journal of respiratory and critical care medicine, 157(2), 1998, pp. 658-664
Authors:
BERSTEN AD
DOYLE IR
DAVIDSON KG
BARR HA
NICHOLAS TE
KERMEEN F
Citation: Ad. Bersten et al., SURFACTANT COMPOSITION REFLECTS LUNG OVERINFLATION AND ARTERIAL OXYGENATION IN PATIENTS WITH ACUTE LUNG INJURY, The European respiratory journal, 12(2), 1998, pp. 301-308
Authors:
BERSTEN AD
DAVIDSON K
NICHOLAS TE
DOYLE IR
Citation: Ad. Bersten et al., RESPIRATORY MECHANICS AND SURFACTANT IN THE ACUTE RESPIRATORY-DISTRESS SYNDROME, Clinical and experimental pharmacology and physiology, 25(11), 1998, pp. 955-963
Citation: Ir. Doyle et al., SURFACTANT PROTEINS-A AND PROTEINS-B ARE ELEVATED IN PLASMA OF PATIENTS WITH ACUTE RESPIRATORY-FAILURE, American journal of respiratory and critical care medicine, 156(4), 1997, pp. 1217-1229
Citation: Ir. Doyle et al., DIFFERENTIAL CHANGES IN SP-A AND DISATURATED PHOSPHOLIPIDS IN THE ISOLATED-PERFUSED RAT LUNG AND IN-VIVO, American journal of physiology. Lung cellular and molecular physiology, 15(3), 1996, pp. 374-382
Citation: G. Yogalingam et al., EXPRESSION AND DISTRIBUTION OF SURFACTANT PROTEINS AND LYSOZYME AFTERPROLONGED HYPERPNEA, American journal of physiology. Lung cellular and molecular physiology, 14(3), 1996, pp. 320-330
Citation: Ir. Doyle et al., SERUM SURFACTANT PROTEIN-A LEVELS IN PATIENTS WITH ACUTE CARDIOGENIC PULMONARY-EDEMA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME, American journal of respiratory and critical care medicine, 152(1), 1995, pp. 307-317
Citation: Ir. Doyle et al., CALCIUM-OXALATE CRYSTAL MATRIX EXTRACT - THE MOST POTENT MACROMOLECULAR INHIBITOR OF CRYSTAL-GROWTH AND AGGREGATION YET TESTED IN UNDILUTEDHUMAN URINE IN-VITRO, Urological research, 23(1), 1995, pp. 53-62
Citation: Ir. Doyle et al., DISTRIBUTION OF SURFACTANT PROTEIN-A IN RAT LUNG, American journal of respiratory cell and molecular biology, 11(4), 1994, pp. 405-415
Citation: K. Suzuki et al., URINARY GLYCOSAMINOGLYCANS ARE SELECTIVELY INCLUDED INTO CALCIUM-OXALATE CRYSTALS PRECIPITATED FROM WHOLE HUMAN URINE, Scanning microscopy, 8(3), 1994, pp. 523-530
Citation: Amf. Stapleton et al., IMMUNOHISTOCHEMICAL DISTRIBUTION AND QUANTIFICATION OF CRYSTAL MATRIXPROTEIN, Kidney international, 44(4), 1993, pp. 817-824
Citation: Rl. Ryall et al., THE DEPENDENCE OF THE MEASUREMENT OF CRYSTAL-GROWTH ON THE STATE OF CRYSTAL AGGREGATION - IMPLICATIONS FOR UROLITHIASIS RESEARCH, Journal of crystal growth, 133(1-2), 1993, pp. 87-94
Citation: Ir. Doyle et al., DISTRIBUTION OF SURFACTANT PROTEIN-A (SP-A) IN RAT LUNG, The American review of respiratory disease, 147(4), 1993, pp. 142-142
Citation: Ir. Doyle et al., RELATIONSHIP BETWEEN SURFACTANT PROTEIN-A (SP-A), DISATURATED PHOSPHOLIPIDS AND CHOLESTEROL IN RATS INVIVO, The American review of respiratory disease, 147(4), 1993, pp. 143-143